MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
6. Technology Transfer (T2), NonDilutive Funding: Strategy Development
* T2ToolBox
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: New York City
Applied Therapeutics, Inc. (NASDAQ: APLT)*
Organization & Developments: Applied Therapeutics
Parents
Applied Therapeutics, Inc. (NASDAQ: APLT)*
Children
*Applied Therapeutics, Inc (NASDAQ: APLT) is a biopharmaceutical company focused on developing a pipeline of product candidates against validated molecular targets in indications of high unmet medical need.
2020: Bad to worse for Applied Therapeutics as FDA slaps partial clinical hold on rare drug
2021: Applied Therapeutics And The Murky World Of Biopharma Development
2023: Applied Therapeutics: Capital Raise Forthcoming
2024: Applied Therapeutics Receives Complete Response Letter
2024: Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer
2024: Applied Therapeutics: FDA Denial Of Govorestat NDA As Problematic As It Was Unexpected
2024: Applied Therapeutics: FDA Stance Change For Advisory Panel Bodes Well For Review
2024: Applied Therapeutics: Multiple Inflection Points Could Generate Substantial Value_ seekingalpha.com
2024: Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible_seekingalpha.com
2024: Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade)_seekingalpha.com
2024: FDA rejects Applied filing for rare disease approval on clinical grounds, sinking stock
2024: FDA Rejects Applied Therapeutics' Govorestat for Classic Galactosemia Treatment
Jumps
Finance & Acquisitions: Applied Therapeutics
Key People: Applied Therapeutics